stoxline Quote Chart Rank Option Currency Glossary
  
Phreesia, Inc. (PHR)
23.58  -0.22 (-0.92%)    04-12 16:00
Open: 23.62
High: 23.88
Volume: 652,556
  
Pre. Close: 23.8
Low: 23.24
Market Cap: 1,312(M)
Technical analysis
2024-04-12 4:51:30 PM
Short term     
Mid term     
Targets 6-month :  28.69 1-year :  30.78
Resists First :  24.56 Second :  26.36
Pivot price 23.21
Supports First :  21.65 Second :  18.02
MAs MA(5) :  23.46 MA(20) :  23.29
MA(100) :  22.97 MA(250) :  24.76
MACD MACD :  -0.3 Signal :  -0.5
%K %D K(14,3) :  57 D(3) :  55
RSI RSI(14): 49.7
52-week High :  34.97 Low :  12.05
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ PHR ] has closed below upper band by 35.8%. Bollinger Bands are 37.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 23.92 - 24.04 24.04 - 24.13
Low: 22.96 - 23.09 23.09 - 23.19
Close: 23.39 - 23.59 23.59 - 23.76
Company Description

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.

Headline News

Fri, 12 Apr 2024
Phreesia, Inc. (NYSE:PHR) Insider Janet Gunzburg Sells 2,768 Shares - MarketBeat

Fri, 12 Apr 2024
Janet Gunzburg Sells 2817 Shares of Phreesia, Inc. (NYSE:PHR) Stock - Defense World

Fri, 12 Apr 2024
Have Insiders Sold Phreesia Shares Recently? - Simply Wall St

Fri, 12 Apr 2024
At US$23.80, Is Phreesia, Inc. (NYSE:PHR) Worth Looking At Closely? - Simply Wall St

Fri, 12 Apr 2024
Janet Gunzburg Sells 1709 Shares of Phreesia, Inc. (NYSE:PHR) Stock - Defense World

Fri, 12 Apr 2024
Balaji Gandhi Sells 7778 Shares of Phreesia, Inc. (NYSE:PHR) Stock - Defense World

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Healthcare Information Services
Shares Out 56 (M)
Shares Float 54 (M)
Held by Insiders 4.7 (%)
Held by Institutions 95.1 (%)
Shares Short 2,240 (K)
Shares Short P.Month 2,290 (K)
Stock Financials
EPS -2.51
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 4.46
Profit Margin -38.5 %
Operating Margin -46.7 %
Return on Assets (ttm) -22.3 %
Return on Equity (ttm) -50.8 %
Qtrly Rev. Growth 45.7 %
Gross Profit (p.s.) 0
Sales Per Share 6.31
EBITDA (p.s.) -1.99
Qtrly Earnings Growth 0 %
Operating Cash Flow -32 (M)
Levered Free Cash Flow 2 (M)
Stock Valuations
PE Ratio -9.4
PEG Ratio 0
Price to Book value 5.28
Price to Sales 3.73
Price to Cash Flow -41.07
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android